Ischemic mitral valve regurgitation grade II-III: Correction in patients with impaired left ventricular function undergoing simultaneous coronary revascularization
E. Prifti et al., Ischemic mitral valve regurgitation grade II-III: Correction in patients with impaired left ventricular function undergoing simultaneous coronary revascularization, J HEART V D, 10(6), 2001, pp. 754-762
Background and aim of the study: Mitral valve regurgitation (MVR), occurrin
g as a result of myocardial ischemia and global left ventricular (IV) dysfu
nction, is predictive of poor outcome. The study aim was to assess the feas
ibility of mitral valve surgery concomitant with coronary artery bypass gra
fting (CABG) in patients with ischemic MVR grade II-III and impaired IV fun
ction.
Methods: Between January 1996 and July 2000, 99 patients with grade II and
III ischemic MVR and IV ejection fraction (LVEF) 17-30% underwent either co
mbined mitral valve surgery and CABG (group I, n = 49) or isolated CABG (gr
oup II, n = 50). LVEF (%), IV end-diastolic diameter (LVEDD; mm), IV end-di
astolic pressure (LVEDP; mmHg), IV end-systolic diameter (LVESD; min) respe
ctively were 27.5 +/- 5, 67.7 +/- 7, 27.7 +/- 4 and 51.4 +/- 7 in group I v
ersus 27.8 +/- 4, 67.5 +/- 6, 27.5 +/- 5 and 51.2 +/- 6 in group II. In gro
up I, mitral valve repair was performed in 43 patients (88%) and replacemen
t in six (12%).
Results: Preoperative data analysis showed no difference between groups. Fi
ve patients (10%) died in group I, compared with six (12%) in group II (p =
NS). Within six months of surgery, IV function and geometry improved signi
ficantly in group I versus group II (LVEF, p <0.001; LVEDD, p = 0.002; LVES
D, p = 0.003, LVEDP, p <0.001); only mild improvements were seen in group I
I. The regurgitation fraction decreased significantly in group I patients a
fter surgery (p <0.001). Cardiac index increased significantly in groups I
and II (p <0.001 and p = 0.03, respectively). In group I at follow up, four
of six patients undergoing mitral valve replacement died, compared with fi
ve of 43 patients (11.5%) undergoing mitral valve repair (p = 0.007). At th
ree years, the overall survival in group II was significantly lower than in
group I (p <0.009).
Conclusion: Both MV repair and replacement preserving subvalvular apparatus
in patients with impaired IV function offered acceptable outcome in terms
of morbidity and survival. Surgical correction of grade II-III WR in patien
ts with impaired IV function should be taken into consideration as it provi
des better survival and improves IV function.